Pacific Biosciences of California, Inc. Common Stock (NASDAQ: PACB) last traded at $2.10, down 9.87% on the session. The quote above updates while this page is open; the figures below are drawn from Pacific Biosciences of California, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pacific Biosciences of California, Inc. Common Stock trades on NASDAQ under the ticker PACB. Its market capitalisation is $652.74 million.
Valuation measures for Pacific Biosciences of California, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $652.74M |
|---|---|
| Enterprise value | $1.38B |
| Price / sales | 4.10 |
| Beta | 2.26 |
Trailing-twelve-month figures tagged in Pacific Biosciences of California, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $159.27M |
|---|---|
| Net income (TTM) | -$131.39M |
| EPS (TTM) | -$0.410 |
| Gross margin | 36.38% |
| Operating margin | -83.53% |
| Cash | $61.00M |
Range and volume for PACB over the past 52 weeks.
| 52-week high | $3.44 |
|---|---|
| 52-week low | $1.07 |
| Volume | 12.07M |
| Average volume | 10.51M |
| Previous close | $2.33 |
Dividend history for Pacific Biosciences of California, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
Invest a chosen dollar amount in Pacific Biosciences of California, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PACB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.